Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration

Clinical trial NCT05190744 · COMPLETED

Trial details

NCT number: NCT05190744
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Autosomal Dominant Polycystic Kidney Disease Nephrogenic Diabetes Insipidus Acquired Nephrogenic Diabetes Insipidus Congenital Nephrogenic Diabetes Insipidus

Start date: 2022-09-01
Primary completion: 2025-12-08
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.